Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple device accurately measure balance in Parkinson's?

NCT ID NCT07327346

Knowledge-focused Sponsor: Hasan Kalyoncu University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a device called GYKO can reliably measure balance in people with Parkinson's disease during walking tests. Twenty-five participants will perform two common balance tasks while wearing the device, and their results will be compared between two raters and again one week later. No treatment is given—the goal is simply to see if the device provides consistent and valid measurements.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide a reliable, low-cost way to measure balance problems in Parkinson's disease, helping doctors track disease progression more accurately.
What could go wrong
This is a small, early-stage reliability study with only 25 participants. It does not test any treatment, so even if the device works well, it won't directly improve patient health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 25 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Individuals aged 50-85 years with idiopathic Parkinson's disease (Hoehn \& Yahr stages 1-3) who can walk independently and participate in TUG, L-Test, and GYKO assessments.

Ages

50 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of idiopathic Parkinson's disease * Hoehn \& Yahr stage 1-3 * Ability to walk independently with or without an assistive device * Ability to follow verbal instructions * Age 50-85 Exclusion Criteria: * Other neurological, vestibular, or musculoskeletal disorders affecting balance * Deep brain stimulation (DBS) implant * Severe visual or auditory impairment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson disease

Contacts and locations

Locations

  • Hasan Kalyoncu University

    Gaziantep, Şahinbey, 27000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.